NEW YORK (GenomeWeb News) – Lab21, a Cambridge, UK-based clinical lab and companion diagnostics developer, has purchased a majority share of molecular diagnostics firm Biotec Laboratories.

The Ipswich, UK-based diagnostics firm has focused on infectious diseases since its creation in 1993. It also has been distributing some of Lab21's diagnostics products through its global network of distributors in 80 countries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.